• Adida, C., Berrebi, D., Peuchmaur, M., Reyes-Mugica, M., Altieri, D.C. (1998) Anti-apoptosis gene, survivin, and prognosis of neuroblastoma. Lancet, 351, 882883.
  • Ambrosini, G., Adida, C., Altieri, D. (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nature Medicine, 3, 917921.
  • Boldin, M.P., Goncharov, T.M., Goltsev, Y.V., Wallach, D. (1996) Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/Apo-1-and TNF receptor-induced cell death. Cell, 85, 803815.
  • Conway, E.M., Pollefeyt, S., Cornelissen, J., DeBaere, I., Steiner-Mosonyi, M., Ong, K., Baens, M., Collen, D., Schuh, A.C. (2000) Three differentially expressed survivin cDNA variants encode proteins with distinct anti-apoptotic functions. Blood, 95, 14351442.
  • Goltsev, Y.V., Kovalenko, A.V., Arnold, E., Varfolomeev, E.E., Brodianski, V.M., Wallach, D. (1997) CASH, a novel caspase homologue with death effector domains. Journal of Biological Chemistry, 272, 1964119644.DOI: 10.1074/jbc.272.32.19641
  • Grenet, J., Teitz, T., Wei, T., Valentine, V., Kidd, V.J. (1999) Structure and chromosome localization of the human CASP8 gene. Gene, 226, 225232.DOI: 10.1016/s0378-1119(98)00565-4
  • Horiuchi, T., Himeji, D., Tsukamoto, H., Harashima, S., Hashimura, C., Hayashi, K. (2000) Dominant expression of a novel splice variant of caspase-8 in human peripheral blood lymphocytes. Biochemistry and Biophysics Research Communication, 271, 77881.
  • Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S., Sameshima, M., Hase, A., Seto, Y., Nagata, S. (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell, 66, 233243.
  • Kamihira, S., Yamada, Y., Hirakata, Y., Tsuruda, K., Sugahara, K., Tomonaga, M., Maeda, T., Tsukasaki, K., Atogami, S., Kobayashi, N. (1997) Quantitative characterization and potential function of membrane Fas/APO-1 (CD95) receptors on leukaemic cells from chronic B and T lymphoid leukaemias. British Journal of Haematology, 99, 858865.
  • Kamihira, S., Yamada, Y., Tomonaga, M., Sugahara, K., Tsuruda, K. (1999) Discrepant expression of membrane and soluble isoforms of Fas (CD95/Apo-1) in adult T-cell leukaemia: soluble Fas isoform is an independent risk factor for prognosis. British Journal of Haematology, 107, 851860.
  • Kawasaki, H., Altieri, D.C., Lu, C.D., Toyoda, M., Tenjo, T., Tanigawa, N. (1998) Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancers. Cancer Research, 85, 50715074.
  • Kerr, J.F.R., Wyllie, A.H., Currie A.R. (1972) Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. British Journal of Cancer, 26, 239257.
  • Kinoshita, K., Kamihira, S., Yamada, Y., Amagasaki, T., Ikeda, S., Momita, S., Ichimaru, M. (1982) Adult T-cell leukaemia-lymphoma in the Nagasaki district. In: Adult T-Cell Leukaemia and Related Diseases (ed. by M.Hanaoka, K.Takatsuki & M. Shimoyama), pp. 167184. Japan Scientific Societies Press, Tokyo.
  • Komada, Y., Inaba, H., Zhou, Y.-W., Tanaka, S., Azuma, E., Sakurai, M. (1997) mRNA expression of Fas receptor (CD95)-associated proteins (FAP-1, FADD, and RIP) in human leukaemia/lymphoma cell lines. British Journal of Haematology, 99, 325330.
  • Maeda, T., Yamada, Y., Moriuchi, R., Sugahara, K., Tsuruda, K., Joh, T., Atogami, S., Tsukasaki, K., Tomonaga, M., Kamihira, S. (1999) Fas gene mutation in the progression of adult T-cell leukemia. Journal of Experimental Medicine, 189, 10631071.
  • Mahotka, C., Wenzel, M., Springer E., Gabbert, H.E., Gerharz, C.D. (1999) Survivin-Δ Ex3 and Survivin-2B: Two novel splice variants of the apoptosis inhibitor survivin with different anti-apoptotic properties. Cancer Research, 59, 60976102.
  • Martin, S.J. (1997) Apoptosis and cancer: an overview. In: Apoptosis and Cancer (ed. byS.J.Martin), pp. 18. Karger Landes System, Basel.
  • Monzo, M., Rosell, R., Felip, E., Astudillo, J., Sanchez, J.J., Maestre, J., Martin, C., Font, A., Barnadas A., Abod, A. (1999) A novel anti-apoptosis gene: re-expression of survivin mRNA as a prognostic marker in non-small cell lung cancers. Journal of Clinical Oncology, 17, 21002104.
  • Nagata, S. & Golstein, P. (1995) The Fas death factor. Science, 267, 14491456.
  • Seto, T., Irie, S., Kitada, S., Reed, J.C. (1995) FAP-1: a protein tyrosine phosphatase that associates with Fas. Science, 268, 411415.
  • Shimoyama, M. et al. & members of the lymphoma study group 1984–87 (1991) Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia/lymphoma. British Journal of Haematology, 79, 428437.
  • Sugahara, K., Yamada, Y., Hirakata, Y., Matsuda, Y., Tsuruda, K., Tomonaga, M., Maeda, T., Atogami, S., Tsukasaki, K., Kamihira, S. (1997) Soluble and membrane isoforms of Fas/CD95 in fresh adult T-cell leukaemia (ATL) cells and ATL-cell lines. International Journal of Cancer, 72, 128132.DOI: 10.1002/(sici)1097-0215(19970703)72:1<128::aid-ijc18>;2-f
  • Tepper, C.G. & Seldin, M.F. (1999) Modulation of caspase-8 and FLICE-inhibitory protein expression as a potential mechanism of Epstein-Barr virus tumourigenesis in Burkitt's lymphoma. Blood, 94, 17271737.
  • Trauth, B.C., Klas, C., Peters, A.M.J., Matzku, S., Moller, P., Falk, W., Debatin, K.M., Krammer, P.H. (1989) Monoclonal antibody mediated tumour regression by induction of apoptosis. Science, 245, 301305.
  • Yamada, Y., Ohomoto, Y., Hata, T., Yamamura, M., Murata, K., Tsukasaki, K., Kohno, T., Cheng, Y., Kamihira, S., Tomonaga, M. (1996) Features of the cytokines secreted by adult T-cell leukaemia (ATL) cells. Leukemia and Lymphoma, 21, 443447.
  • Yonehara, S., Ishii, A., Yonehara, M. (1989) A cell killing monoclonal antibody (anti-Fas) to a cell surface antigen co-down regulated with the receptor of tumour necrosis factor. Journal of Experimental Medicine, 169, 17471756.